Ignite Creation Date:
2025-12-25 @ 12:57 AM
Ignite Modification Date:
2025-12-26 @ 1:32 PM
Study NCT ID:
NCT00224393
Status:
COMPLETED
Last Update Posted:
2023-05-30
First Post:
2005-09-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis
Sponsor:
The Cleveland Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-02
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2005-08-31
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-21
First Submit QC Date:
None
Study First Post Date:
2005-09-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-25
Last Update Post Date:
2023-05-30
Last Update Post Date Type:
ACTUAL